Michael J. Rossi - Mar 7, 2025 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role
PRESIDENT & CEO, Director
Signature
/s/ John LaRocca, Attorney-in-Fact
Stock symbol
YMAB
Transactions as of
Mar 7, 2025
Transactions value $
-$20,368
Form type
4
Date filed
3/11/2025, 08:17 PM
Previous filing
Jan 22, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YMAB Common Stock Sale -$20.4K -3.92K -2.78% $5.20 137K Mar 7, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Nondiscretionary sale to cover tax liability associated with the vesting and settlement of restricted stock units.